The cutting edge: Promising oncology radiotracers in clinical development

JD Oldan, MG Pomper, RA Werner, T Higuchi… - Diagnostic and …, 2024 - Elsevier
Molecular imaging moves forward with the development of new imaging agents, and among
these are new radiotracers for nuclear medicine applications, particularly positron emission …

The Clinical Role of CXCR4-Targeted PET on Lymphoproliferative Disorders: A Systematic Review

M Zamanian, D Albano, G Treglia, A Rizzo… - Journal of Clinical …, 2024 - mdpi.com
Background/Objectives: We conducted a comprehensive investigation to explore the
pathological expression of the CXCR4 receptor in lymphoproliferative disorders (LPDs) …